Soluble FAS Ligand as a Biomarker of Disease Recurrence in Differentiated Thyroid Cancer

Cancer - United States
doi 10.1002/cncr.27937
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Analysis of Serum Soluble Fas and Soluble Fas Ligand in Patients With Silicosis.

Sangyo eiseigaku zasshi = Journal of occupational health
MedicineEnvironmentalPublic HealthToxicologyOccupational Health
1998English

Soluble Fas Ligand and Soluble Fas in Ocular Fluid of Patients With Uveitis

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2000English

Role of Thyroglobulin as a Predictor of the Evolution of Disease in Differentiated Thyroid Cancer

Endocrine Abstracts
2015English

Preoperative Charcoal Suspension Tattoo for the Detection of Differentiated Thyroid Cancer Recurrence

Molecular and Clinical Oncology
Cancer ResearchOncology
2019English

Differentiated Thyroid Cancer

Archives of Surgery
1998English

Differentiated Thyroid Cancer in Childhood: A Literature Update

Hormones
MedicineEndocrinologyMetabolismDiabetes
2018English

Evaluation of Soluble Concentration Fas and Fas Ligand in Maternal and Cord Blood 3rd Trimester of Pregnancy

Ginekologia Polska
GynecologyObstetrics
2018English

Management of Differentiated Thyroid Cancer in Pregnancy

Journal of Thyroid Research
EndocrinologyMetabolismDiabetes
2011English

Serum Thyroglobulin in Differentiated Thyroid Cancer.

BMJ
1979English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy